Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis
about
Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlightMarine Origin Polysaccharides in Drug Delivery Systems.Orphan nuclear receptor HNF4G promotes bladder cancer growth and invasion through the regulation of the hyaluronan synthase 2 geneWT1-associated protein is a novel prognostic factor in pancreatic ductal adenocarcinoma.Antitumor activity of sulfated hyaluronic acid fragments in pre-clinical models of bladder cancer.Expression and roles of Wilms' tumor 1-associating protein in glioblastoma.Differential expression of SDF-1 isoforms in bladder cancerPrognostic impact of hyaluronan and its regulators in pancreatic ductal adenocarcinoma.The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.Molecular characterization of kidney cancer: association of hyaluronic acid family with histological subtypes and metastasis.Emerging roles for hyaluronidase in cancer metastasis and therapy.Tissue hyaluronan expression, as reflected in the sputum of lung cancer patients, is an indicator of malignancyHyaluronidase Hyal1 Increases Tumor Cell Proliferation and Motility through Accelerated Vesicle Trafficking.Dietary supplement 4-methylumbelliferone: an effective chemopreventive and therapeutic agent for prostate cancer.Decreased expression of hyaluronan synthase 1 and 2 associates with poor prognosis in cutaneous melanoma.CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL).Molecular diagnostic trends in urological cancer: biomarkers for non-invasive diagnosis.C-X-C chemokine receptor 7: a functionally associated molecular marker for bladder cancer.Loss of Glycogen Debranching Enzyme AGL Drives Bladder Tumor Growth via Induction of Hyaluronic Acid SynthesisSonic hedgehog signaling directly targets Hyaluronic Acid Synthase 2, an essential regulator of phalangeal joint patterning.Chemokine and chemokine receptor expression in kidney tumors: molecular profiling of histological subtypes and association with metastasis.Extracellular matrix and heart development.Urinary biomarkers of bladder cancer: an update and future perspectives.Therapeutic targeting of hyaluronan in the tumor stroma.Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers.Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies.Targeting hyaluronic acid family for cancer chemoprevention and therapy.Sugars in the microenvironment: the sticky problem of HA turnover in tumors.Hyaluronan synthase 1: a mysterious enzyme with unexpected functionsKey signaling pathways in the muscle-invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment.Role of HYAL1 expression in primary breast cancer in the formation of brain metastases.Targeting hyaluronidase for cancer therapy: antitumor activity of sulfated hyaluronic acid in prostate cancer cells.Hyaluronan suppresses prostate tumor cell proliferation through diminished expression of N-cadherin and aberrant growth factor receptor signaling.Fluorescence detection of hyaluronidaseHyaluronan synthase 2 expressed by cancer-associated fibroblasts promotes oral cancer invasion.Altered expression of hyaluronan, HAS1-2, and HYAL1-2 in oral lichen planus.Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival.Human hyaluronic acid synthase-1 promotes malignant transformation via epithelial-to-mesenchymal transition, micronucleation and centrosome abnormalities.Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets.
P2860
Q26766075-026FDBB1-71D4-40F3-8328-6CD8BEF81F88Q26767227-3823CD73-CC26-4A32-A78A-9071C7FB9F27Q29347539-2364647E-CEF4-480C-ADB0-90DB8A9F628DQ33598160-013265DF-340C-42E3-A1AB-3287C9E3D694Q33648449-55C43149-C808-408A-9DAB-01010B3811FCQ34298191-4B8BCF3E-E836-4C7A-A065-C03B1760836BQ34342390-5B4FDED4-F2A0-47CD-BE85-FC76C4F5DB0DQ34385867-22531CF8-D8EF-473F-A627-E21BE4290A98Q34999699-D25B4D8C-0A64-4528-AA96-F83576727B3EQ35597200-C4B71354-0DC3-4F10-A7ED-04D42DDCE069Q35653691-822590E2-1EBA-407F-8A06-4CAFFD1B7BEDQ35750872-E612ED66-7D81-423E-9260-134BE3E951B4Q35860935-FBCF4CFA-1DC9-425A-9244-07C692B6A881Q36009814-A3051461-5639-4D36-A241-0681B8D3AB59Q36019013-C357F802-22C9-43F0-9670-478B2B6FD54FQ36123305-D1F8C5AF-7030-4192-AC9E-D54BB4C4645EQ36190604-DF2E1416-0B83-41DE-B317-F10AF826F800Q36287809-FA78AC79-6D0B-4362-A4B8-15FFEF1A1B57Q36642643-EEBCD82D-F11D-405E-9961-C1E6A8B4CED4Q37287061-5321358F-A71E-4008-AA22-F9E8DEC687D6Q37573641-4AFF5ADC-1463-4034-A2BB-6DDE56C4E9D1Q37880711-0785568B-59BB-456B-BA03-3AB0F24DA75CQ38138607-6CD0E416-F46A-49D8-88A3-79B2F2FA51FDQ38161392-FBBD9009-6CDF-409B-BC99-CA2F87B86663Q38199975-2B2A51BB-A5DD-4259-B608-0A58F9DDCD62Q38216129-0DD00E0B-FF51-45C7-9CF2-A03BD82A168CQ38235792-6E9D9E82-FEC6-4AA3-8668-5DC025DC8CB6Q38260975-08487E57-CA8D-4E09-BE64-348109098C71Q38362645-ABF56B91-68D5-4C59-A298-5690DC5382FDQ38627721-3C075B8F-E6F4-4976-863C-907DE8FA195DQ38974913-7764D802-5832-4A9E-A2E6-5D36C098DDB7Q39545737-995C9F6D-0015-4BCA-AC24-2AE6125FBF17Q39593897-4AC27ADD-D7F7-4F37-A884-E689F94F38C5Q41778324-70263509-21C3-45D5-B520-87D54C0B35BBQ41791561-A1C9F452-CEDE-4BF8-93D6-3318EDE59C00Q42468887-F322BB40-4832-4A24-8CFD-33067E1A0692Q44168152-DEADC847-A317-4E0C-96EC-6B788153F9DDQ47105832-147A35CB-4FEF-4E30-9FCD-53261CDCC007Q47281580-3BA10AA9-719C-4F03-85A6-B6EB9B03E2F9Q47874868-25E8799F-C942-4B38-BD00-06B1F683862C
P2860
Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Association of hyaluronic acid ...... cancer diagnosis and prognosis
@ast
Association of hyaluronic acid ...... cancer diagnosis and prognosis
@en
Association of hyaluronic acid ...... cancer diagnosis and prognosis
@nl
type
label
Association of hyaluronic acid ...... cancer diagnosis and prognosis
@ast
Association of hyaluronic acid ...... cancer diagnosis and prognosis
@en
Association of hyaluronic acid ...... cancer diagnosis and prognosis
@nl
prefLabel
Association of hyaluronic acid ...... cancer diagnosis and prognosis
@ast
Association of hyaluronic acid ...... cancer diagnosis and prognosis
@en
Association of hyaluronic acid ...... cancer diagnosis and prognosis
@nl
P2093
P2860
P356
P1433
P1476
Association of hyaluronic acid ...... cancer diagnosis and prognosis
@en
P2093
Axel S Merseburger
Diogo O Escudero
Kristell Acosta
Mario W Kramer
Mark Soloway
Obi O Ekwenna
Roozbeh Golshani
Soum D Lokeshwar
Vinata B Lokeshwar
P2860
P304
P356
10.1002/CNCR.25565
P407
P577
2010-10-19T00:00:00Z